MedicarePartD.guide

A non-government resource built from CMS public data

Fetzima on BlueCross Rx Value (S5953-001)

levomilnacipran hydrochloride

Covered, with step therapy.

Tier 4 (non-preferred drug). Quantity limit of 56 per 365 days.

$46.28
Patient pays / month, after deductible
$92.56
Patient pays / month, before the $615.00 deductible
$138.84
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

FETZIMA Kit at a preferred retail pharmacy, from the plan's negotiated price of $92.56 for a month. Other covered strengths are listed below.

Prior authNot required· Step therapy applies· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 5 covered strengths and forms
FormTierPatient pays / monthLimits
FETZIMA 120 mg Capsule, Extended Release4$265.45ST · 30 per 30 days
FETZIMA 20 mg Capsule, Extended Release4$265.49ST · 30 per 30 days
FETZIMA 40 mg Capsule, Extended Release4$265.34ST · 30 per 30 days
FETZIMA 80 mg Capsule, Extended Release4$265.56ST · 30 per 30 days
FETZIMA Kit4$46.28ST · 56 per 365 days

Verify with the plan before prescribing or filling. Member services: (888)645-6025. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5953-001